Anti-cancer Mitochondrial Metabolism Drug CPI-613 Induces Catastrophic ATP Depletion and Cellular Starvation

Text Registration

Anti-cancer Mitochondrial Metabolism Drug CPI-613 Induces Catastrophic ATP Depletion and Cellular Starvation

Status

Published

on 23 Oct 2019

Year of Creation

2019

Moises Ovidio Guardado Rivas

Registration Number

TX0008802398

on 23 Oct 2019

The U.S. Copyright record (Registration Number: TX0008802398) dated 23 Oct 2019, pertains to an electronic file (eService) titled "Anti-cancer Mitochondrial Metabolism Drug CPI-613 Induces Catastrophic ATP Depletion and Cellular Starvation" created in 2019. The copyright holder is Moises Ovidio Guardado Rivas, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Moises Ovidio Guardado Rivas.

Moises Ovidio Guardado Rivas

Application Details

Registration Number

TX0008802398

Registration Date

10/23/2019

Year of Creation

2019

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Moises O Guardado Rivas

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Anti-cancer Mitochondrial Metabolism Drug CPI-613 Induces Catastrophic ATP Depletion and Cellular Starvation

Author Statement: Moises O. Guardado Rivas Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Anti-cancer Mitochondrial Metabolism Drug CPI-613 Induces Catastrophic ATP Depletion and Cellular Starvation

Author Statement: Moises O. Guardado Rivas Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.